MEthotrexate Versus TOcilizumab for Treatment of GIant Cell Arteritis: a Multicenter, Randomized, Controlled Trial

NCT03892785 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

230

Enrollment

OTHER

Sponsor class

Conditions

Giant Cell Arteritis

Interventions

DRUG: Prednisone treatment
DRUG: Tocilizumab treatment
DRUG: Methotrexate treatment
OTHER: Questionnaires
BIOLOGICAL: Blood samples

Sponsor

Centre Hospitalier Universitaire Dijon